Basic & Clinical Medicine ›› 2026, Vol. 46 ›› Issue (9): 1287-1292.doi: 10.16352/j.issn.1001-6325.2026.09.1287

• Mini Reviews • Previous Articles     Next Articles

Research progress on the mechanism of action of sterol regulatory element-binding protein(SREBP) in metabolic inflammatory syndrome

ZHANG Yi1, YANG Lijuan1,2, WANG Pingle1*   

  1. 1. Coolege of Traditional Chinese medicine College, Inner Mongolia Medical University, Hohhot 010107;
    2. Department of Rheumatology, Inner Mangolia Autonmous Region Hospital of Traditional Chinese medicine, Hohhot 010102, China
  • Received:2025-09-07 Revised:2025-11-26 Online:2026-09-05 Published:2026-08-18
  • Contact: *wangpingle2007@163.com

Abstract: Sterol regulatory element-binding proteins(SREBPs), key transcription factors in cellular lipid metabolism regulation, play a significant role in the development of metabolic inflammatory response syndrome(MIS). Under prolonged high-fat intake, aberrant expression levels of SREBPs contribute to the pathogenesis of MIS by modulating multiple signaling pathways, including uric acid metabolism, vascular endothelial cell(VEC) proliferation, immune cell activity, and NF-κB/NLRP3 signaling pathway. Furthermore, excessive activation of SREBPs leads to chronic inflammation and impairs the body's ability to regulate inflammation.

Key words: sterol regulatory element-binding protein(SREBP), metabolic inflammatory syndrome, gout, NLRP3 inflammasome, nuclear factor-κB(NF-κB)

CLC Number: